Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2016
17th World Conference on Lung Cancer
Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria
Presentation Date(s):- Dec 4 - 7, 2016
- Total Presentations: 2466
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
JCES01 - Joint IASLC - Chinese Society for Clinical Oncology - Chinese Alliance Against Lung Cancer Session
- Type: Joint Chinese / English Session
- Track:
- Presentations: 28
- Moderators:F.R. Hirsch
- Coordinates: 12/04/2016, 08:00 - 11:45, Stolz 1
-
+
JCES01.03 - Perspectives on Precision Medicine for Early Stage NSCLC
11:25 - 11:45 | Author(s): J. Hu
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA01 - Risk Assessment and Follow up in Surgical Patients
- Type: Oral Session
- Track: Surgery
- Presentations: 8
- Moderators:W. Zhong
- Coordinates: 12/05/2016, 11:00 - 12:30, Schubert 2
-
+
OA01.03 - Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Stage I NSCLC Patients: A Competing Risk Analysis
11:20 - 11:30 | Author(s): T. Eguchi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ED04 - Bronchopulmonary Carcinoids
- Type: Education Session
- Track: SCLC/Neuroendocrine Tumors
- Presentations: 3
- Moderators:V. Gorbunova
- Coordinates: 12/05/2016, 14:30 - 15:45, Lehar 1-2
-
+
ED04.01 - Surgery in Bronchopulmonary Typical and Atypical Carcinoids
14:30 - 15:00 | Author(s): P.L. Filosso
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ED04.02 - Systemic Therapy of Bronchopulmonary Typical and Atypical Carcinoids: Current Status and Perspectives
15:00 - 15:30 | Author(s): E. Baudin
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Q&A
15:30 - 15:30
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P1.03 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Radiology/Staging/Screening
- Presentations: 84
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.03-084 - Implications of 8th Edition TNM Proposal: Invasive vs. Total Size for T Descriptor in pT1a-2bN0M0 Lung Adenocarcinoma
14:30 - 14:30 | Author(s): T. Eguchi
- Abstract
Loading...
-
+
P1.08 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Surgery
- Presentations: 84
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.08-057 - Outcomes between Single Port, Two Port and Three Port VATS Pulmonary Resection
14:30 - 14:30 | Author(s): J. Mu
- Abstract
Loading...
-
+
P2.03a - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 72
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.03a-001 - A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): B. Han
- Abstract
Loading... -
+
P2.03a-012 - Nephrotoxicity in Patients with Advanced NSCLC Receiving Pemetrexed-Based Chemotherapy
14:30 - 14:30 | Author(s): S. Visser
- Abstract
Loading...
-
+
P2.03b - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 98
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.03b-004 - Factors Associated with Brain Metastasis in Patients with Lung Adenocarcinoma after Surgical Resection
14:30 - 14:30 | Author(s): J. Hung
- Abstract
Loading...
-
+
NU05 - Survivorship
- Type: Nurses Session
- Track: Nurses
- Presentations: 4
- Moderators:B. Ivimey
- Coordinates: 12/07/2016, 14:30 - 15:45, Schubert 5
-
+
NU05.02 - Comprehensive Long-Term Care of Lung Cancer Patients: Development of a Novel Thoracic Survivorship Program
14:50 - 15:10 | Author(s): J. Huang
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.02a - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 37
- Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P3.02a-008 - EML4-ALK in Plasma Exosomes from a Cohort of NSCLC Patients
14:30 - 14:30 | Author(s): K. Brinkmann
- Abstract
Loading...
-
+
P3.02b - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 126
- Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P3.02b-042 - Reduction in Peripheral Blood Cytokine Levels Observed in EGFR Mutant (EGFRm) Patients Treated with Erlotinib
14:30 - 14:30 | Author(s): A. Lisberg
- Abstract
Loading...